Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.oret.2018.10.009 | DOI Listing |
Biochemistry
December 2024
Gavin Herbert Eye Institute - Center for Translational Vision Research, Department of Ophthalmology, University of California, Irvine, Irvine, California 92697, United States.
Arrestins halt signal transduction by binding to the phosphorylated C-termini of activated G protein-coupled receptors. Arrestin-1, the first subtype discovered, binds to rhodopsin in rod cells. Mutations in , the gene encoding Arrestin-1, are linked to Oguchi disease, characterized by delayed dark adaptation.
View Article and Find Full Text PDFEye (Lond)
November 2024
UCL Institute of Ophthalmology, University College London, London, UK.
Oman J Ophthalmol
May 2023
Department of Ophthalmology, Rajan Eye Care Hospital Pvt Ltd, Chennai, Tamil Nadu, India.
Ann Med Surg (Lond)
April 2023
Marashi Eye Clinic, Aleppo, Syrian Arab Republic.
Unlabelled: Oguchi disease is a rare autosomal recessive disease that causes congenital stationary blindness, which is distinguished by the Mizuo-Nakamura phenomenon and caused by mutations of rhodopsin kinase gene or the arrestin gene.
Case Presentation: A 5-year-old Syrian female complains of stationary night blindness, investigated by fundus photo and optical coherence photograph and diagnosed as Oguchi disease.
Discussion: Oguchi disease is an autosomal recessive retinal disorder causing stationary nyctalopia.
JAMA Ophthalmol
January 2023
Sankara Nethralaya, Chennai, India.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!